Home LiteratureArticle Details
PMID: 11038187 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.

The Journal of cell biology ·Vol. 151 ·No. 2 ·2000-10-16 ·Pages 413-23

Melikyan GB, Markosyan RM, Hemmati H, Delmedico MK, Lambert DM, Cohen FS

Abstract

Many viral fusion proteins exhibit a six-helix bundle as a core structure. HIV Env-induced fusion was studied to resolve whether membrane merger was due to the transition into the bundle configuration or occurred after bundle formation. Suboptimal temperature was used to arrest fusion at an intermediate stage. When bundle formation was prevented by adding inhibitory peptides at this stage, membranes did not merge upon raising temperature. Inversely, when membrane merger was prevented by incorporating lysophosphatidylcholine (LPC) into cell membranes at the intermediate, the bundle did not form upon optimizing temperature. In the absence of LPC, the six-helix bundle did not form when the temperature of the intermediate was raised for times too short to promote fusion. Kinetic measures showed that after the temperature pulse, cells had not advanced further toward fusion. The latter results indicate that bundle formation is the rate-limiting step between the arrested intermediate and fusion. Electrical measures showed that the HIV Env-induced pore is initially large and grows rapidly. It is proposed that bundle formation and fusion are each contingent on the other and that movement of Env during its transition into the six-helix bundle directly induces the lipid rearrangements of membrane fusion. Because peptide inhibition showed that, at the intermediate stage, the heptad repeats of gp41 have become stably exposed, creation of the intermediate could be of importance in drug and/or vaccine development.

MeSH Terms
CD4-Positive T-Lymphocytes/virology HIV Envelope Protein gp41/chemistry,metabolism HIV-1 Lysophosphatidylcholines/pharmacology Membrane Fusion/drug effects Models, Biological Motion Protein Conformation Receptors, CXCR4 Temperature Thermodynamics
Chemicals
HIV Envelope Protein gp41 Lysophosphatidylcholines Receptors, CXCR4
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Melikyan G B
Department of Molecular Biophysics and Physiology, Rush Medical College, Chicago, Illinois 60612, USA.
Markosyan R M
Hemmati H
Delmedico M K
Lambert D M
Cohen F S
References (56)
56 references, click to expand
  1. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
    J Virol. 1999 Dec;73(12):10346-58 PMID: 10559353
  2. The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation.
    J Cell Biol. 1998 Mar 23;140(6):1369-82 PMID: 9508770
  3. Role of the cytoplasmic tail of ecotropic moloney murine leukemia virus Env protein in fusion pore formation.
    J Virol. 2000 Jan;74(1):447-55 PMID: 10590134
  4. Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation.
    J Mol Biol. 2000 Jan 14;295(2):163-8 PMID: 10623516
  5. Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides.
    Biochemistry. 2000 Feb 22;39(7):1634-42 PMID: 10677212
  6. Factors determining vesicular lipid mixing induced by shortened constructs of influenza hemagglutinin.
    Biochemistry. 2000 Mar 14;39(10):2733-9 PMID: 10704225
  7. The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores.
    Mol Biol Cell. 2000 Apr;11(4):1143-52 PMID: 10749920
  8. Spectroscopic determination of tryptophan and tyrosine in proteins.
    Biochemistry. 1967 Jul;6(7):1948-54 PMID: 6049437
  9. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.
    Cell. 1986 Nov 7;47(3):333-48 PMID: 3094962
  10. Stalk mechanism of vesicle fusion. Intermixing of aqueous contents.
    Eur Biophys J. 1989;17(3):121-9 PMID: 2792021
  11. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding.
    J Exp Med. 1990 Oct 1;172(4):1233-42 PMID: 1698911
  12. The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior to fusion.
    J Biol Chem. 1991 Sep 25;266(27):18404-10 PMID: 1917964
  13. A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope.
    AIDS Res Hum Retroviruses. 1993 Jan;9(1):23-32 PMID: 8094000
  14. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion.
    Cell. 1994 Jan 28;76(2):383-91 PMID: 8293471
  15. Energetics of intermediates in membrane fusion: comparison of stalk and inverted micellar intermediate mechanisms.
    Biophys J. 1993 Nov;65(5):2124-40 PMID: 8298039
  16. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
    Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9770-4 PMID: 7937889
  17. Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1.
    J Virol. 1995 Mar;69(3):1462-72 PMID: 7853478
  18. A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion.
    J Virol. 1995 Jun;69(6):3771-7 PMID: 7538176
  19. The synaptic vesicle cycle: a cascade of protein-protein interactions.
    Nature. 1995 Jun 22;375(6533):645-53 PMID: 7791897
  20. Structure and function of fusion pores in exocytosis and ectoplasmic membrane fusion.
    Curr Opin Cell Biol. 1995 Aug;7(4):509-17 PMID: 7495570
  21. Lipids in biological membrane fusion.
    J Membr Biol. 1995 Jul;146(1):1-14 PMID: 7563032
  22. A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein.
    Biochemistry. 1995 Nov 21;34(46):14955-62 PMID: 7578108
  23. The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide.
    EMBO J. 1996 Apr 1;15(7):1507-14 PMID: 8612573
  24. H+-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region.
    J Biol Chem. 1996 Jun 7;271(23):13417-21 PMID: 8662770
  25. Studies of HIV-1 envelope glycoprotein-mediated fusion using a simple fluorescence assay.
    AIDS. 1996 Mar;10(3):241-6 PMID: 8882662
  26. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41.
    Biochemistry. 1996 Oct 22;35(42):13697-708 PMID: 8885850
  27. Characterization of CD4-gp120 activation intermediates during human immunodeficiency virus type 1 syncytium formation.
    AIDS Res Hum Retroviruses. 1996 Sep 20;12(14):1305-13 PMID: 8891109
  28. SNAREpins: minimal machinery for membrane fusion.
    Cell. 1998 Mar 20;92(6):759-72 PMID: 9529252
  29. Capture of an early fusion-active conformation of HIV-1 gp41.
    Nat Struct Biol. 1998 Apr;5(4):276-9 PMID: 9546217
  30. HIV entry and its inhibition.
    Cell. 1998 May 29;93(5):681-4 PMID: 9630213
  31. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.
    Science. 1998 Jun 19;280(5371):1884-8 PMID: 9632381
  32. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.
    Virology. 1998 Aug 15;248(1):20-34 PMID: 9705252
  33. The synaptic SNARE complex is a parallel four-stranded helical bundle.
    Nat Struct Biol. 1998 Sep;5(9):765-9 PMID: 9731768
  34. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution.
    Nature. 1998 Sep 24;395(6700):347-53 PMID: 9759724
  35. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target.
    Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15613-7 PMID: 9861018
  36. Coiled coils in both intracellular vesicle and viral membrane fusion.
    Cell. 1998 Dec 23;95(7):871-4 PMID: 9875840
  37. Fusion-competent vaccines: broad neutralization of primary isolates of HIV.
    Science. 1999 Jan 15;283(5400):357-62 PMID: 9888845
  38. Structural basis for paramyxovirus-mediated membrane fusion.
    Mol Cell. 1999 Mar;3(3):309-19 PMID: 10198633
  39. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.
    Annu Rev Immunol. 1999;17:657-700 PMID: 10358771
  40. Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion.
    Mol Biol Cell. 1999 Jun;10(6):1821-36 PMID: 10359599
  41. N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil.
    Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8967-72 PMID: 10430879
  42. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype.
    Mol Biol Cell. 1999 Aug;10(8):2759-69 PMID: 10436026
  43. Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection.
    J Virol. 1999 Sep;73(9):7489-96 PMID: 10438838
  44. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements.
    Nat Struct Biol. 1999 Oct;6(10):953-60 PMID: 10504731
  45. Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket.
    Cell. 1999 Oct 1;99(1):103-15 PMID: 10520998
  46. Atomic structure of the ectodomain from HIV-1 gp41.
    Nature. 1997 May 22;387(6631):426-30 PMID: 9163431
  47. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.
    Cell. 1996 Nov 15;87(4):745-56 PMID: 8929542
  48. An early stage of membrane fusion mediated by the low pH conformation of influenza hemagglutinin depends upon membrane lipids.
    J Cell Biol. 1997 Jan 13;136(1):81-93 PMID: 9008705
  49. Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion.
    J Cell Biol. 1997 Mar 10;136(5):995-1005 PMID: 9060465
  50. Core structure of gp41 from the HIV envelope glycoprotein.
    Cell. 1997 Apr 18;89(2):263-73 PMID: 9108481
  51. SNAREs and NSF in targeted membrane fusion.
    Curr Opin Cell Biol. 1997 Aug;9(4):505-12 PMID: 9261050
  52. How lysophosphatidylcholine inhibits cell-cell fusion mediated by the envelope glycoprotein of human immunodeficiency virus.
    Virology. 1997 Sep 1;235(2):201-8 PMID: 9281499
  53. Membrane rearrangements in fusion mediated by viral proteins.
    Trends Microbiol. 1997 Sep;5(9):349-55 PMID: 9294890
  54. Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.
    J Virol. 1998 Feb;72(2):986-93 PMID: 9444991
  55. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41.
    J Cell Biol. 1998 Jan 26;140(2):315-23 PMID: 9442107
  56. Morphological changes and fusogenic activity of influenza virus hemagglutinin.
    Biophys J. 1998 Jan;74(1):54-62 PMID: 9449309
Article Info
Journal
The Journal of cell biology
Abbr.
J Cell Biol
ISSN
0021-9525
Published
2000-10-16
Pages
413-23
Language
English
Region
United States
NLM ID
0375356
PMCID
PMC2192659
Subset
IM
Grants
NIGMS NIH HHS · R01 GM054787 · United States
NIGMS NIH HHS · GM54787 · United States
NIGMS NIH HHS · GM27367 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com